These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9823572)

  • 21. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
    Glaser D
    Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
    [No Abstract]   [Full Text] [Related]  

  • 22. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of response to treatment in chronic hepatitis C].
    Leroy V; Hilleret MN
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B23-31. PubMed ID: 12180294
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic hepatitis C with repeatedly normal transaminase levels].
    Dhumeaux D; Hézode C
    Rom J Gastroenterol; 2002 Jun; 11(2):129-33. PubMed ID: 12145669
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspects of the future of therapy for patients infected with a high viral load and interferon-resistant subtype of HCV.
    Matsumoto A; Kiyosawa K
    J Gastroenterol; 2002; 37(9):766-8. PubMed ID: 12375156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

  • 31. APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers.
    Su TH; Kao JH; Chen DS
    Hepatology; 2007 Jun; 45(6):1586-7; author reply 1587-8. PubMed ID: 17538939
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of hepatitis C. Paris 27-28 February 2002].
    Ann Med Interne (Paris); 2002 Nov; 153(7):467-77. PubMed ID: 12598833
    [No Abstract]   [Full Text] [Related]  

  • 33. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.
    Gopal K; Johnson TC; Gopal S; Walfish A; Bang CT; Suwandhi P; Pena-Sahdala HN; Clain DJ; Bodenheimer HC; Min AD
    Hepatology; 2006 Aug; 44(2):335-40. PubMed ID: 16871569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of interferon in hepatitis B and C.
    Schalm SW
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):87-99. PubMed ID: 19739400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can interferon prolong life?
    Esteban R
    Hepatology; 2003 Aug; 38(2):292-4. PubMed ID: 12883472
    [No Abstract]   [Full Text] [Related]  

  • 38. Current treatment for chronic hepatitis C.
    Davis GL
    Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C].
    Giménez-Barcons M; Tajahuerce A; Sáiz JC
    Gastroenterol Hepatol; 1998 Oct; 21(8):404-12. PubMed ID: 9844281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term outcomes of interferon therapy for chronic hepatitis].
    Dou XG; Zhao LR
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):10. PubMed ID: 21272451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.